Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis

Tumor necrosis factor inhibitors (TNFi) are widely used for the treatment of patients with rheumatoid arthritis (RA), however a considerable percentage of patients discontinued the therapy. The aim of this study is to explore real-world TNFi survival, stratified for seropositivity, and to determine...

Full description

Bibliographic Details
Main Authors: Borja Hernández-Breijo, Claudia M. Brenis, Chamaida Plasencia-Rodríguez, Ana Martínez-Feito, Marta Novella-Navarro, Dora Pascual-Salcedo, Alejandro Balsa
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Medicine
Subjects:
rheumatoid arthritis
TNF inhibitor
drug survival
methotrexate
seropositivity
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.692557/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.692557/full

Similar Items